73/100 B+ · Elevated risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.

✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)

NEVRO CORP

Active Company 📍 Redwood City, Ca Instruments & measuring devices

Company · RC 0001444380

B+

Overview

NEVRO CORP is a company registered in Redwood City, Ca, United States. The company operates in the instruments & measuring devices sector. With reported revenue of 408.5M USD in 2024. Its TraceComp score of 73 (B+) indicates moderate risk with some areas to watch.

Company Information

Registration Number
0001444380
Legal Form
Company
Address
Redwood City, Ca

Financial Profile

Latest filed accounts: FY 2024

Revenue (2024) 408,518,000 USD
Net Income -113,439,000 USD
Total Assets 553,841,000 USD
Altman Z 0.75 distress

Multi-year financials & ratios

1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

No officers on record.

Research Output

Active research organization. 266 publications · 6,962 citations · h-index 45 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Medicine (68%) · Neuroscience (21%) · Biochemistry, Genetics and Molecular Biology (8%).

See full research profile — top researchers & publications →

Source: OpenAlex (CC0). Objective publication & citation counts.

Patent Portfolio

Active patent holder. 197 patents · 196 active · 197 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • Net loss reported in FY 2024
  • Altman Z-Score in the distress zone — elevated insolvency risk on the model

Data Sources & Freshness

Data sourced from: bulk register.